速递丨10余款癌症管线正在临床推进,和誉医药展示创新管线布局与前沿临床进展

医药观澜
Yesterday

10月30日,和誉医药宣布2025研发日在上海成功举办,展示了公司最新创新管线布局与前沿临床进展。和誉医药创始人兼首席执行官徐耀昌博士表示,和誉医药持续致力于在肿瘤及其他疾病领域开发具有差异化的创新疗法,以满足中国及全球患者尚未满足的关键临床需求。为实现这一目标,公司将研发置于战略核心位置,视其为驱动未来增长和实现可持续回报的核心引擎,并持续加大研发投入。高选择性小分子FGFR4抑制剂依帕戈替尼(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10